
A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).
A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).
A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate


A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).
A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).
A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate
A global consumer packaged goods company wanted to understand the effectiveness of an herbal blend on menopause symptoms and quality of life (QoL).

A global consumer packaged goods company needed clinical evidence on the effectiveness of an herbal blend for relieving menopause symptoms and improving quality of life (QoL), including hard-to-quantify symptoms like hot flashes.
The randomized, double-blind, placebo-controlled study was conducted fully remotely with no physical research site. Apart from two local lab blood draws, participants completed all study procedures in-app. 130 women consumed the study product daily, updated e-diaries, and completed digital questionnaires at weekly intervals. One-touch, real-time ePRO reporting reduced recall bias, and a dedicated "hot flash indicator" button let participants log each episode as it happened, giving the sponsor rich data on hot flash frequency and severity. Changes from baseline were assessed over 12 weeks.
• The study delivered complete, analyzable efficacy and safety data over 12 weeks, with significant improvement from baseline in hot flash frequency and severity
• Regular notifications and study-team follow-up kept participants engaged
• Ease of in-app reporting contributed to an 87% retention rate

VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration.
.png)
A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.